BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open 1 SUPPLEMENTARY INFORMATION 2 3 The effect of intensive treatment for schistosomiasis on immune responses to vaccines among 4 rural Ugandan island adolescents: randomised controlled trial protocol A for the ‘POPulation 5 differences in VACcine responses’ (POPVAC) programme 6 Gyaviira Nkurunungi1,¶,*, Ludoviko Zirimenya1,¶, Jacent Nassuuna1,¶, Agnes Natukunda1,¶, Prossy N 7 Kabuubi1, Emmanuel Niwagaba1, Gloria Oduru1, Grace Kabami1, Rebecca Amongin1, Alex Mutebe 1, 8 Milly Namutebi1, Christopher Zziwa1, Susan Amongi1, Caroline Ninsiima1, Caroline Onen1, Florence 9 Akello1, Moses Sewankambo1, Samuel Kiwanuka1, Robert Kizindo1, James Kaweesa2, Stephen Cose1,3, 10 Emily L Webb4, Alison M Elliott1,3 for the POPVAC trial team 11 12 1Immunomodulation and Vaccines Programme, Medical Research Council/Uganda Virus Research 13 Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda 14 Research Unit, Entebbe, Uganda 15 2Vector Control Division, Ministry of Health, Kampala, Uganda 16 3Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United 17 Kingdom 18 4MRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School 19 of Hygiene and Tropical Medicine, London, United Kingdom 20 ¶These authors contributed equally 21 *Correspondence: Gyaviira Nkurunungi;
[email protected] Nkurunungi G, et al. BMJ Open 2021; 11:e040426. doi: 10.1136/bmjopen-2020-040426 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open Table S1.